Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer Treatment Induced Thrombocytopenia”

37 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 37 results

Testing effectiveness (Phase 2)Study completedNCT00413283
What this trial is testing

Dose/ Schedule Finding Trial of Romiplostim for Chemotherapy-Induced Thrombocytopenia (CIT) in Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Lung CancerChemotherapy-Induced ThrombocytopeniaNon-Small Cell Lung Cancer+5 more
Amgen 63
Large-scale testing (Phase 3)WithdrawnNCT05261646
What this trial is testing

A Clinical Study of Hetrombopag Olamine Tablets in Adults Receiving 21-day Cycles of Chemotherapy for Solid Tumours, Who Are Delayed for at Least 1 Week From Their Scheduled Cycle Because of Chemotherapy-induced Thrombocytopenia

Who this might be right for
Chemotherapy-Induced Thrombocytopenia
Jiangsu HengRui Medicine Co., Ltd.
Testing effectiveness (Phase 2)Study completedNCT01147809
What this trial is testing

Safety and Efficacy Study for Solid Tumor Patients Treated With Eltrombopag

Who this might be right for
Thrombocytopaenia
GlaxoSmithKline 130
Testing effectiveness (Phase 2)Looking for participantsNCT07257809
What this trial is testing

Herombopag Treated T-DM1 Induced Platelet Reduction

Who this might be right for
Thrombocytopenia
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 56
Testing effectiveness (Phase 2)Ended earlyNCT00074165
What this trial is testing

Treating Patients With Recurrent PCNSL With Carboplatin/BBBD and Adding Rituxan To The Treatment Regimen

Who this might be right for
Brain and Central Nervous System TumorsDrug/Agent Toxicity by Tissue/OrganLymphoma+1 more
OHSU Knight Cancer Institute 17
Testing effectiveness (Phase 2)Looking for participantsNCT06433830
What this trial is testing

Hetrombopag for the Thrombocytopenia Induced by Concurrent Chemoradiotherapy

Who this might be right for
ThrombocytopeniaRadiotherapy Side Effect
Sir Run Run Shaw Hospital 50
Large-scale testing (Phase 3)Looking for participantsNCT06456528
What this trial is testing

QL0911 for the Treatment of Cancer Treatment-Induced Thrombocytopenia

Who this might be right for
Cancer Treatment-Induced Thrombocytopenia
Qilu Pharmaceutical Co., Ltd. 235
Not applicableUnknownNCT03049774
What this trial is testing

The Recombinant Human Interleukin-11 (I) (Baijieyi) for Prevention and Treatment of Chemotherapy-induced Thrombocytopenia in Patients With Malignant Tumor

Who this might be right for
Chemotherapy-induced Thrombocytopenia
Angde Biotech Pharmaceutical Co., Ltd. 2,000
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06898983
What this trial is testing

Efficacy and Safety Study of Romiplostim N01 for Cancer Treatment-induced Thrombocytopenia (CTIT) in the Treatment of Leukemia

Who this might be right for
Cancer Treatment-induced Thrombocytopenia (CTIT)
Anhui Provincial Hospital 97
Testing effectiveness (Phase 2)Study completedNCT05394285
What this trial is testing

A Clinical Study of Hetrombopag Olamine Tablets for Thrombocytopenia Induced by Anti-tumor Treatment in Advanced Breast Cancer

Who this might be right for
Breast Cancer
Henan Cancer Hospital 60
Large-scale testing (Phase 3)Study completedNCT03976882
What this trial is testing

Hetrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia in Subjects With Malignancy.

Who this might be right for
Chemotherapy-Induced Thrombocytopenia
Jiangsu HengRui Medicine Co., Ltd. 129
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07252375
What this trial is testing

A Clinical Study of Hetrombopag for Prevention of Thrombocytopenia Induced by Gemcitabine Plus Cisplatin in the Treatment of Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma (NPC)CTIT-Chemotherapy Induced Thrombocytopenia
Fujian Cancer Hospital 35
Not applicableStudy completedNCT04609891
What this trial is testing

Avatrombopag on the Treatment of Thrombocytopenia Induced by Chemotherapy of Malignant Tumors

Who this might be right for
Thrombocytopenia
Anhui Provincial Cancer Hospital 74
Large-scale testing (Phase 3)Looking for participantsNCT06759636
What this trial is testing

A Study on the Treatment of CTIT of the Efficacy and Safety With Romiplostim N01 Compared to Recombinant Human Interleukin-11

Who this might be right for
CTIT: Cancer Therapy Induced Thrombocytopenia
The First Affiliated Hospital with Nanjing Medical University 88
Testing effectiveness (Phase 2)Ended earlyNCT03195010
What this trial is testing

Management of Platelet Transfusion Therapy in Patients With Blood Cancer or Treatment-Induced Thrombocytopenia

Who this might be right for
Acute Biphenotypic LeukemiaAcute Lymphoblastic LeukemiaAcute Myeloid Leukemia+11 more
Fred Hutchinson Cancer Center 4
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05944211
What this trial is testing

Hetrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia(CIT) in Patients With Acute Myeloid Leukemia

Who this might be right for
Chemotherapy-Induced Thrombocytopenia
RenJi Hospital 72
Large-scale testing (Phase 3)Active Not RecruitingNCT05864014
What this trial is testing

Hetrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia in Adults With Solid Tumors.

Who this might be right for
Chemotherapy-Induced Thrombocytopenia
Jiangsu HengRui Medicine Co., Ltd. 213
Testing effectiveness (Phase 2)Ended earlyNCT01676961
What this trial is testing

Romiplostim in Increasing Low Platelet Counts in Patients With Multiple Myeloma Receiving Chemotherapy

Who this might be right for
Refractory Multiple MyelomaStage I Multiple MyelomaStage II Multiple Myeloma+2 more
NYU Langone Health 5
Testing effectiveness (Phase 2)UnknownNCT04797182
What this trial is testing

Avatrombopag for the Primary Prevention of Thrombocytopenia Induced by Cytarabine-based Chemotherapy in Patients With Lymphoma

Who this might be right for
ThrombocytopeniaCytarabine Causing Adverse Effects in Therapeutic UseLymphoma
Sun Yat-sen University 46
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07408648
What this trial is testing

A Clinical Study on the Efficacy and Safety of Hetrombopag in the Treatment of Thrombocytopenia Induced by Gynecological Tumor Therapy

Who this might be right for
Chemotherapy Induced Thrombocytopenia
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 244
Load More Results